Clearmind Medicine Inc
CMND2.740USD
+0.130+4.98%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
14.74MMarket Cap
LossP/E TTM
More Details of Clearmind Medicine Inc Company
Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The Company researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 19 patent families including 31 granted patents.
Clearmind Medicine Inc Info
Ticker SymbolCMND
Company nameClearmind Medicine Inc
IPO dateAug 10, 2021
CEOZuloff-Shani (Adi)
Number of employees- -
Security typeOrdinary Share
Fiscal year-endAug 10
Address101-1220 West 6Th Avenue
CityVANCOUVER
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryCanada
Postal codeV6H 1A5
Phone16042601566
Websitehttps://www.clearmindmedicine.com/
Ticker SymbolCMND
IPO dateAug 10, 2021
CEOZuloff-Shani (Adi)
Company Executives of Clearmind Medicine Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Amitay Weiss
Mr. Amitay Weiss
Independent Chairman of the Board
Independent Chairman of the Board
39.83K
--
Mr. Alan Rootenberg
Mr. Alan Rootenberg
Chief Financial Officer
Chief Financial Officer
24.75K
+161.59%
Mr. Asaf Itzhaik
Mr. Asaf Itzhaik
Independent Director
Independent Director
--
-100.00%
Mr. Oz Adler, CPA
Mr. Oz Adler, CPA
Independent Director
Independent Director
--
-100.00%
Mr. Yehonatan Shachar
Mr. Yehonatan Shachar
Independent Director
Independent Director
--
--
Dr. Adi Zuloff-Shani
Dr. Adi Zuloff-Shani
Chief Executive Officer
Chief Executive Officer
--
--
Prof. Mark Haden
Prof. Mark Haden
Vice President - Business Development
Vice President - Business Development
--
-100.00%
Ms. Hila Kiron-Revach
Ms. Hila Kiron-Revach
Director
Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Amitay Weiss
Mr. Amitay Weiss
Independent Chairman of the Board
Independent Chairman of the Board
39.83K
--
Mr. Alan Rootenberg
Mr. Alan Rootenberg
Chief Financial Officer
Chief Financial Officer
24.75K
+161.59%
Mr. Asaf Itzhaik
Mr. Asaf Itzhaik
Independent Director
Independent Director
--
-100.00%
Mr. Oz Adler, CPA
Mr. Oz Adler, CPA
Independent Director
Independent Director
--
-100.00%
Mr. Yehonatan Shachar
Mr. Yehonatan Shachar
Independent Director
Independent Director
--
--
Dr. Adi Zuloff-Shani
Dr. Adi Zuloff-Shani
Chief Executive Officer
Chief Executive Officer
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Wed, Dec 3
Updated: Wed, Dec 3
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Capitalink Ltd.
9.97%
L.I.A. Pure Capital Ltd
9.97%
Daniel (Nissim)
5.51%
AdvisorShares Investments, LLC
0.37%
Shani (Adi Zuloff)
0.09%
Other
74.09%
Shareholders
Shareholders
Proportion
Capitalink Ltd.
9.97%
L.I.A. Pure Capital Ltd
9.97%
Daniel (Nissim)
5.51%
AdvisorShares Investments, LLC
0.37%
Shani (Adi Zuloff)
0.09%
Other
74.09%
Shareholder Types
Shareholders
Proportion
Corporation
19.94%
Individual Investor
5.73%
Investment Advisor
0.42%
Research Firm
0.05%
Other
73.86%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
18
281.13K
2.83%
--
2025Q3
20
281.13K
17.81%
-308.29K
2025Q2
21
589.42K
18.96%
-12.36K
2025Q1
18
601.77K
18.55%
-350.88K
2024Q4
18
612.80K
20.27%
-89.61K
2024Q3
17
702.42K
8.27%
+411.62K
2024Q2
15
290.80K
5.30%
+12.32K
2024Q1
15
281.81K
3.72%
+163.87K
2023Q4
13
96.03K
1.96%
+64.13K
2023Q3
13
31.90K
2.51%
+20.39K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
AdvisorShares Investments, LLC
205.93K
3.83%
-15.00K
-6.79%
Jun 30, 2025
Shani (Adi Zuloff)
54.23K
1.01%
+52.57K
+3153.45%
Oct 31, 2024
Weiss (Amitay)
39.83K
0.74%
-15.31K
-27.76%
Dec 01, 2024
Virtu Americas LLC
--
0%
-39.48K
-100.00%
Mar 31, 2025
Rootenberg (Alan)
24.75K
0.46%
+15.29K
+161.59%
May 13, 2025
Susquehanna International Group, LLP
--
0%
-23.98K
-100.00%
Jun 30, 2024
Shachar (Yehonatan Samuel)
12.50K
0.23%
--
--
Dec 01, 2024
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
AdvisorShares Psychedelics ETF
1.16%
Fidelity Nasdaq Composite Index ETF
0%
AdvisorShares Psychedelics ETF
Proportion1.16%
Fidelity Nasdaq Composite Index ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Dec 11, 2025
Merger
40→1
Nov 21, 2023
Merger
30→1
Nov 21, 2023
Merger
30→1
Nov 21, 2023
Merger
30→1
Nov 21, 2023
Merger
30→1
Date
Type
Ratio
Dec 11, 2025
Merger
40→1
Nov 21, 2023
Merger
30→1
Nov 21, 2023
Merger
30→1
Nov 21, 2023
Merger
30→1
Nov 21, 2023
Merger
30→1
FAQs
Who are the top five shareholders of Clearmind Medicine Inc?
The top five shareholders of Clearmind Medicine Inc are:
AdvisorShares Investments, LLC holds 205.93K shares, accounting for 3.83% of the total shares.
Shani (Adi Zuloff) holds 54.23K shares, accounting for 1.01% of the total shares.
Weiss (Amitay) holds 39.83K shares, accounting for 0.74% of the total shares.
Virtu Americas LLC holds 0.00 shares, accounting for 0.00% of the total shares.
Rootenberg (Alan) holds 24.75K shares, accounting for 0.46% of the total shares.
AdvisorShares Investments, LLC holds 205.93K shares, accounting for 3.83% of the total shares.
Shani (Adi Zuloff) holds 54.23K shares, accounting for 1.01% of the total shares.
Weiss (Amitay) holds 39.83K shares, accounting for 0.74% of the total shares.
Virtu Americas LLC holds 0.00 shares, accounting for 0.00% of the total shares.
Rootenberg (Alan) holds 24.75K shares, accounting for 0.46% of the total shares.
What are the top three shareholder types of Clearmind Medicine Inc?
The top three shareholder types of Clearmind Medicine Inc are:
Capitalink Ltd.
L.I.A. Pure Capital Ltd
Daniel (Nissim)
Capitalink Ltd.
L.I.A. Pure Capital Ltd
Daniel (Nissim)
How many institutions hold shares of Clearmind Medicine Inc (CMND)?
As of 2025Q4, 18 institutions hold shares of Clearmind Medicine Inc, with a combined market value of approximately 281.13K, accounting for 2.83% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -14.98%.
What is the biggest source of revenue for Clearmind Medicine Inc?
In --, the -- business generated the highest revenue for Clearmind Medicine Inc, amounting to -- and accounting for --% of total revenue.
